Advisors Asset Management, Inc. Legend Biotech Corp Transaction History
Advisors Asset Management, Inc.
- $5.1 Billion
- Q1 2024
A detailed history of Advisors Asset Management, Inc. transactions in Legend Biotech Corp stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 4,494 shares of LEGN stock, worth $208,072. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,494
Previous 2,499
79.83%
Holding current value
$208,072
Previous $150,000
68.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding LEGN
# of Institutions
213Shares Held
63.6MCall Options Held
1.09MPut Options Held
525K-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$507 Million0.08% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$277 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.38MShares$249 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.61MShares$121 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA2.39MShares$110 Million0.02% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $7.75B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...